Ilife Clinics And Research Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 15-07-2024
- Paid Up Capital ₹ 1.00 Cr
as on 15-07-2024
- Company Age 18 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 7.50 M
as on 15-07-2024
- Revenue %
(FY 2022)
- Profit 92.24%
(FY 2022)
- Ebitda 97.69%
(FY 2022)
- Net Worth -1.58%
(FY 2022)
- Total Assets -27.77%
(FY 2022)
About Ilife Clinics And Research
The Corporate was formerly known as Moneymitra Professional Services Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 1.00 Cr.
The company currently has active open charges totaling ₹7.50 M.
Soham Shukla, Sameer Nanavati, and Keyur Doshi serve as directors at the Company.
- CIN/LLPIN
U85110GJ2006PTC048490
- Company No.
048490
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Jun 2006
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Vadodara, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Ilife Clinics And Research?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sameer Nanavati  | Director | 16-Jun-2006 | Current |
| Keyur Doshi | Director | 16-Jun-2006 | Current |
| Soham Shukla | Director | 16-Jun-2006 | Current |
Financial Performance and Corporate Structure Insights of Ilife Clinics And Research.
Ilife Clinics And Research Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 92.24% increase in profit. The company's net worth dipped by a decrease of 1.58%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ilife Clinics And Research?
In 2019, Ilife Clinics And Research had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Green World Esg Consultants FoundationActive 10 years 18 daysSameer Nanavati and Keyur Doshi are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 09 Mar 2016 | ₹7.50 M | Open |
How Many Employees Work at Ilife Clinics And Research?
Ilife Clinics And Research has a workforce of 2 employees as of Apr 01, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ilife Clinics And Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ilife Clinics And Research's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
